Importantly, it should be recognized that IgE-associated immune pathomechanisms are located downstream of multiple molecular pathomechanisms of AD, in which type-2 immunity (mediated by IL-4/IL-13) plays a central role. This evidence concerns the gene IL13 and Alzheimer disease.